Clinical Characteristics and Prognosis Associated with Multiple Primary Cancers in Breast Cancer Patients
Breast cancer is one of the most common malignancies worldwide and the second most common cancer among Korean women. The prognosis of breast cancer is poor in patients with other primary cancers. However, there have been few clinical studies regarding this issue. Therefore, we analyzed the character...
Saved in:
Published in | Journal of breast cancer Vol. 21; no. 1; pp. 62 - 69 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Korea (South)
Korean Breast Cancer Society
01.03.2018
한국유방암학회 |
Subjects | |
Online Access | Get full text |
ISSN | 1738-6756 2092-9900 |
DOI | 10.4048/jbc.2018.21.1.62 |
Cover
Abstract | Breast cancer is one of the most common malignancies worldwide and the second most common cancer among Korean women. The prognosis of breast cancer is poor in patients with other primary cancers. However, there have been few clinical studies regarding this issue. Therefore, we analyzed the characteristics and prognosis of patients with breast cancer with multiple primary cancers (MPCs).
Data from the Korean Breast Cancer Society Registry were analyzed. Data from enrolled patients who underwent surgery for breast cancer were analyzed for differences in prognosis dependent on the presence of MPCs, and which MPC characteristics affected their prognosis.
Among the 41,841 patients analyzed, 913 patients were found to have MPCs, accounting for 950 total MPCs. There was a significant difference in survival rates between the breast cancer only group and the MPC group. The 5-year survival rates were 93.6% and 86.7% and the 10-year survival rates were 87.5% and 70.4%, respectively. Among the 913 patients with MPCs, patients with two or more MPCs had significantly worse prognoses than patients with a single MPC. With respect to the time interval between breast cancer and MPC occurrence, patients with a 5-year or greater interval had significantly better prognoses than patients with less than 1 year between occurrences. Among MPCs, thyroid cancer was the most common primary cancer. However, this type was not related to the prognosis of breast cancer. Gynecologic cancer, colorectal cancer, upper gastrointestinal cancer, and lung cancer were related to breast cancer prognosis.
MPCs were a poor prognostic factor for patients with breast cancer. Two or more MPCs and a shorter time interval between occurrences were worse prognostic factors. Although MPCs were a poor prognostic factor, thyroid cancer did not affect the prognosis of patients with breast cancer. |
---|---|
AbstractList | Breast cancer is one of the most common malignancies worldwide and the second most common cancer among Korean women. The prognosis of breast cancer is poor in patients with other primary cancers. However, there have been few clinical studies regarding this issue. Therefore, we analyzed the characteristics and prognosis of patients with breast cancer with multiple primary cancers (MPCs).
Data from the Korean Breast Cancer Society Registry were analyzed. Data from enrolled patients who underwent surgery for breast cancer were analyzed for differences in prognosis dependent on the presence of MPCs, and which MPC characteristics affected their prognosis.
Among the 41,841 patients analyzed, 913 patients were found to have MPCs, accounting for 950 total MPCs. There was a significant difference in survival rates between the breast cancer only group and the MPC group. The 5-year survival rates were 93.6% and 86.7% and the 10-year survival rates were 87.5% and 70.4%, respectively. Among the 913 patients with MPCs, patients with two or more MPCs had significantly worse prognoses than patients with a single MPC. With respect to the time interval between breast cancer and MPC occurrence, patients with a 5-year or greater interval had significantly better prognoses than patients with less than 1 year between occurrences. Among MPCs, thyroid cancer was the most common primary cancer. However, this type was not related to the prognosis of breast cancer. Gynecologic cancer, colorectal cancer, upper gastrointestinal cancer, and lung cancer were related to breast cancer prognosis.
MPCs were a poor prognostic factor for patients with breast cancer. Two or more MPCs and a shorter time interval between occurrences were worse prognostic factors. Although MPCs were a poor prognostic factor, thyroid cancer did not affect the prognosis of patients with breast cancer. Breast cancer is one of the most common malignancies worldwide and the second most common cancer among Korean women. The prognosis of breast cancer is poor in patients with other primary cancers. However, there have been few clinical studies regarding this issue. Therefore, we analyzed the characteristics and prognosis of patients with breast cancer with multiple primary cancers (MPCs).PURPOSEBreast cancer is one of the most common malignancies worldwide and the second most common cancer among Korean women. The prognosis of breast cancer is poor in patients with other primary cancers. However, there have been few clinical studies regarding this issue. Therefore, we analyzed the characteristics and prognosis of patients with breast cancer with multiple primary cancers (MPCs).Data from the Korean Breast Cancer Society Registry were analyzed. Data from enrolled patients who underwent surgery for breast cancer were analyzed for differences in prognosis dependent on the presence of MPCs, and which MPC characteristics affected their prognosis.METHODSData from the Korean Breast Cancer Society Registry were analyzed. Data from enrolled patients who underwent surgery for breast cancer were analyzed for differences in prognosis dependent on the presence of MPCs, and which MPC characteristics affected their prognosis.Among the 41,841 patients analyzed, 913 patients were found to have MPCs, accounting for 950 total MPCs. There was a significant difference in survival rates between the breast cancer only group and the MPC group. The 5-year survival rates were 93.6% and 86.7% and the 10-year survival rates were 87.5% and 70.4%, respectively. Among the 913 patients with MPCs, patients with two or more MPCs had significantly worse prognoses than patients with a single MPC. With respect to the time interval between breast cancer and MPC occurrence, patients with a 5-year or greater interval had significantly better prognoses than patients with less than 1 year between occurrences. Among MPCs, thyroid cancer was the most common primary cancer. However, this type was not related to the prognosis of breast cancer. Gynecologic cancer, colorectal cancer, upper gastrointestinal cancer, and lung cancer were related to breast cancer prognosis.RESULTSAmong the 41,841 patients analyzed, 913 patients were found to have MPCs, accounting for 950 total MPCs. There was a significant difference in survival rates between the breast cancer only group and the MPC group. The 5-year survival rates were 93.6% and 86.7% and the 10-year survival rates were 87.5% and 70.4%, respectively. Among the 913 patients with MPCs, patients with two or more MPCs had significantly worse prognoses than patients with a single MPC. With respect to the time interval between breast cancer and MPC occurrence, patients with a 5-year or greater interval had significantly better prognoses than patients with less than 1 year between occurrences. Among MPCs, thyroid cancer was the most common primary cancer. However, this type was not related to the prognosis of breast cancer. Gynecologic cancer, colorectal cancer, upper gastrointestinal cancer, and lung cancer were related to breast cancer prognosis.MPCs were a poor prognostic factor for patients with breast cancer. Two or more MPCs and a shorter time interval between occurrences were worse prognostic factors. Although MPCs were a poor prognostic factor, thyroid cancer did not affect the prognosis of patients with breast cancer.CONCLUSIONMPCs were a poor prognostic factor for patients with breast cancer. Two or more MPCs and a shorter time interval between occurrences were worse prognostic factors. Although MPCs were a poor prognostic factor, thyroid cancer did not affect the prognosis of patients with breast cancer. Purpose: Breast cancer is one of the most common malignancies worldwide and the second most common cancer among Korean women. The prognosis of breast cancer is poor in patients with other primary cancers. However, there have been few clinical studies regarding this issue. Therefore, we analyzed the characteristics and prognosis of patients with breast cancer with multiple primary cancers (MPCs). Methods: Data from the Korean Breast Cancer Society Registry were analyzed. Data from enrolled patients who underwent surgery for breast cancer were analyzed for differences in prognosis dependent on the presence of MPCs, and which MPC characteristics affected their prognosis. Results: Among the 41,841 patients analyzed, 913 patients were found to have MPCs, accounting for 950 total MPCs. There was a significant difference in survival rates between the breast cancer only group and the MPC group. The 5-year survival rates were 93.6% and 86.7% and the 10-year survival rates were 87.5% and 70.4%, respectively. Among the 913 patients with MPCs, patients with two or more MPCs had significantly worse prognoses than patients with a single MPC. With respect to the time interval between breast cancer and MPC occurrence, patients with a 5-year or greater interval had significantly better prognoses than patients with less than 1 year between occurrences. Among MPCs, thyroid cancer was the most common primary cancer. However, this type was not related to the prognosis of breast cancer. Gynecologic cancer, colorectal cancer, upper gastrointestinal cancer, and lung cancer were related to breast cancer prognosis. Conclusion: MPCs were a poor prognostic factor for patients with breast cancer. Two or more MPCs and a shorter time interval between occurrences were worse prognostic factors. Although MPCs were a poor prognostic factor, thyroid cancer did not affect the prognosis of patients with breast cancer. KCI Citation Count: 13 |
Author | Oh, Se Jeong Jung, Yongsik Park, Woo-Chan Sun, Woo Young Lee, Han-Byoel Park, Min Ho Kim, Bong Kyun Lee, Jina Song, Jeong-Yoon |
AuthorAffiliation | 1 Department of Surgery, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon, Korea 6 Department of Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea 5 Department of Surgery, Ajou University School of Medicine, Suwon, Korea Department of Surgery, Daejeon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Daejeon, Korea 2 Department of Surgery, Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine, Seoul, Korea 4 Department of Surgery, Chonnam National University Medical School, Gwangju, Korea 3 Department of Surgery, Seoul National University College of Medicine, Seoul, Korea |
AuthorAffiliation_xml | – name: 4 Department of Surgery, Chonnam National University Medical School, Gwangju, Korea – name: 5 Department of Surgery, Ajou University School of Medicine, Suwon, Korea – name: 6 Department of Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea – name: 1 Department of Surgery, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon, Korea – name: 3 Department of Surgery, Seoul National University College of Medicine, Seoul, Korea – name: Department of Surgery, Daejeon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Daejeon, Korea – name: 2 Department of Surgery, Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine, Seoul, Korea |
Author_xml | – sequence: 1 givenname: Bong Kyun surname: Kim fullname: Kim, Bong Kyun organization: Department of Surgery, Daejeon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Daejeon, Korea – sequence: 2 givenname: Se Jeong surname: Oh fullname: Oh, Se Jeong organization: Department of Surgery, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon, Korea – sequence: 3 givenname: Jeong-Yoon surname: Song fullname: Song, Jeong-Yoon organization: Department of Surgery, Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine, Seoul, Korea – sequence: 4 givenname: Han-Byoel surname: Lee fullname: Lee, Han-Byoel organization: Department of Surgery, Seoul National University College of Medicine, Seoul, Korea – sequence: 5 givenname: Min Ho surname: Park fullname: Park, Min Ho organization: Department of Surgery, Chonnam National University Medical School, Gwangju, Korea – sequence: 6 givenname: Yongsik surname: Jung fullname: Jung, Yongsik organization: Department of Surgery, Ajou University School of Medicine, Suwon, Korea – sequence: 7 givenname: Woo-Chan surname: Park fullname: Park, Woo-Chan organization: Department of Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea – sequence: 8 givenname: Jina surname: Lee fullname: Lee, Jina organization: Department of Surgery, Daejeon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Daejeon, Korea – sequence: 9 givenname: Woo Young surname: Sun fullname: Sun, Woo Young organization: Department of Surgery, Daejeon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Daejeon, Korea |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29628985$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002327984$$DAccess content in National Research Foundation of Korea (NRF) |
BookMark | eNp1kc1v1DAQxS3Uim4Ld07IRzgkHX8nF6Ql4qNSERUqZ8txnK7brL3Y3lb892S7SwVInEaa-b03Y79TdBRicAi9IlBz4M35bW9rCqSpKalJLekztKDQ0qptAY7QgijWVFIJeYJOc74FkJwp9Ryd0FbSpm3EAvlu8sFbM-FuZZKxxSWfi7cZmzDgqxRvQsw-42XO0XpT3IAffFnhL9up-M3kZsSvTfqJOxOsSxn7gN8nZ3I5dPCVKd6Fkl-g49FM2b081DP0_eOH6-5zdfn100W3vKwsZ1AqIhXvpaJ8ZGNLmW0YI4aSvhVmoD0XfaP4qABGEFQCHcHYnvdmIFxwJRiwM_R27xvSqO-s19H4x3oT9V3Sy2_XF5qBFIq2M_tuz262_doNdr4zmUlv9m96VP49CX41-9xr0TTQSjUbvDkYpPhj63LRa5-tmyYTXNxmTYEyTghjdEZf_7nracnvLGYA9oBNMefkxieEgN7Free49S5uTYkmWu485T8S68v833F3rZ_-L_wFr52v6A |
CitedBy_id | crossref_primary_10_1038_s41598_023_30812_8 crossref_primary_10_1002_prm2_12122 crossref_primary_10_1097_CM9_0000000000001969 crossref_primary_10_1021_acssensors_4c02246 crossref_primary_10_12677_ACM_2022_124490 crossref_primary_10_12998_wjcc_v10_i34_12678 crossref_primary_10_1007_s10147_019_01430_0 crossref_primary_10_1002_cam4_4351 crossref_primary_10_54097_ijbls_v2i3_8648 crossref_primary_10_12998_wjcc_v11_i7_1513 crossref_primary_10_2147_BCTT_S321390 crossref_primary_10_7717_peerj_13528 crossref_primary_10_1515_biol_2022_0465 crossref_primary_10_16956_jes_2020_20_4_88 crossref_primary_10_3389_fonc_2022_840431 crossref_primary_10_1007_s10549_021_06122_w crossref_primary_10_1111_ijcp_14663 |
Cites_doi | 10.3322/caac.21412 10.4143/crt.2013.215 10.1186/1471-2407-12-138 10.3322/caac.21262 10.14735/amko201411 10.1158/1055-9965.EPI-06-0782 10.1007/978-1-59745-416-2_5 10.1089/thy.2016.0655 10.1371/journal.pone.0185485 10.3349/ymj.2015.56.5.1213 10.1177/000313480807400806 10.3343/alm.2016.36.5.463 10.1097/MD.0000000000003299 10.1093/jnci/dju289 10.7314/APJCP.2015.16.12.4921 10.1159/000447348 10.1158/1055-9965.EPI-15-0833 10.18632/oncotarget.9547 10.1056/NEJMoa050518 10.4048/jbc.2017.20.1.1 10.1177/147323001103900237 10.1111/j.1349-7006.2012.02254.x 10.7326/0003-4819-152-7-201004060-00009 10.1016/j.prp.2017.01.003 10.1016/S1470-2045(11)70061-4 10.4048/jbc.2016.19.1.1 10.1002/cncr.30248 |
ContentType | Journal Article |
Copyright | 2018 Korean Breast Cancer Society 2018 Korean Breast Cancer Society |
Copyright_xml | – notice: 2018 Korean Breast Cancer Society 2018 Korean Breast Cancer Society |
CorporateAuthor | Korean Breast Cancer Society |
CorporateAuthor_xml | – name: Korean Breast Cancer Society |
DBID | AAYXX CITATION NPM 7X8 5PM ACYCR |
DOI | 10.4048/jbc.2018.21.1.62 |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Korean Citation Index |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2092-9900 |
EndPage | 69 |
ExternalDocumentID | oai_kci_go_kr_ARTI_3065729 PMC5880967 29628985 10_4048_jbc_2018_21_1_62 |
Genre | Journal Article |
GrantInformation_xml | – fundername: ; – fundername: ; grantid: HI14C1062 |
GroupedDBID | --- 5-W 5GY 8JR 8XY 9ZL AAYXX ADBBV ADRAZ AENEX ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL CITATION DIK DU5 EF. GROUPED_DOAJ HYE KQ8 M48 O5R O5S PGMZT RPM NPM 7X8 5PM ACYCR |
ID | FETCH-LOGICAL-c430t-1674b6724f3f923c8331a21b95ad2b45b874f700f052602f0acb4bad145475303 |
IEDL.DBID | M48 |
ISSN | 1738-6756 |
IngestDate | Tue Nov 21 21:39:36 EST 2023 Thu Aug 21 18:21:43 EDT 2025 Fri Jul 11 06:25:11 EDT 2025 Thu Jan 02 22:55:00 EST 2025 Tue Jul 01 01:56:43 EDT 2025 Thu Apr 24 23:11:08 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Multiple primary neoplasms Breast neoplasms Prognosis Survival |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c430t-1674b6724f3f923c8331a21b95ad2b45b874f700f052602f0acb4bad145475303 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 https://ejbc.kr/search.php?where=aview&id=10.4048/jbc.2018.21.1.62&code=0096JBC&vmode=FULL |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.4048/jbc.2018.21.1.62 |
PMID | 29628985 |
PQID | 2023411332 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_3065729 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5880967 proquest_miscellaneous_2023411332 pubmed_primary_29628985 crossref_primary_10_4048_jbc_2018_21_1_62 crossref_citationtrail_10_4048_jbc_2018_21_1_62 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2018-03-01 |
PublicationDateYYYYMMDD | 2018-03-01 |
PublicationDate_xml | – month: 03 year: 2018 text: 2018-03-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Korea (South) |
PublicationPlace_xml | – name: Korea (South) |
PublicationTitle | Journal of breast cancer |
PublicationTitleAlternate | J Breast Cancer |
PublicationYear | 2018 |
Publisher | Korean Breast Cancer Society 한국유방암학회 |
Publisher_xml | – name: Korean Breast Cancer Society – name: 한국유방암학회 |
References | Arjunan (10.4048/jbc.2018.21.1.62_ref12) 2016; 10 Romaniuk (10.4048/jbc.2018.21.1.62_ref11) 2017; 213 Berry (10.4048/jbc.2018.21.1.62_ref4) 2005; 353 Mariotto (10.4048/jbc.2018.21.1.62_ref6) 2007; 16 Gursel (10.4048/jbc.2018.21.1.62_ref19) 2011; 39 Yoshimoto (10.4048/jbc.2018.21.1.62_ref22) 1985; 15 Silva-Vieira (10.4048/jbc.2018.21.1.62_ref28) 2017; 27 Shan (10.4048/jbc.2018.21.1.62_ref9) 2017; 12 Nielsen (10.4048/jbc.2018.21.1.62_ref27) 2016; 25 Mai (10.4048/jbc.2018.21.1.62_ref24) 2016; 122 DeSantis (10.4048/jbc.2018.21.1.62_ref3) 2017; 67 Choi (10.4048/jbc.2018.21.1.62_ref15) 2016; 95 Kim (10.4048/jbc.2018.21.1.62_ref7) 2015; 47 Albright (10.4048/jbc.2018.21.1.62_ref16) 2012; 12 Eliyatkin (10.4048/jbc.2018.21.1.62_ref8) 2015; 16 Kikuchi (10.4048/jbc.2018.21.1.62_ref25) 2013; 33 Bu-Ali (10.4048/jbc.2018.21.1.62_ref10) 2008; 74 Tabuchi (10.4048/jbc.2018.21.1.62_ref21) 2012; 103 Soerjomataram (10.4048/jbc.2018.21.1.62_ref17) 2009; 471 Henderson (10.4048/jbc.2018.21.1.62_ref29) 2010; 152 Lee (10.4048/jbc.2018.21.1.62_ref20) 2015; 56 Park (10.4048/jbc.2018.21.1.62_ref23) 2016; 36 Park (10.4048/jbc.2018.21.1.62_ref14) 2017; 20 Berrington (10.4048/jbc.2018.21.1.62_ref26) 2011; 12 Munoz (10.4048/jbc.2018.21.1.62_ref5) 2014; 106 Torre (10.4048/jbc.2018.21.1.62_ref1) 2015; 65 Min (10.4048/jbc.2018.21.1.62_ref2) 2016; 19 Castro (10.4048/jbc.2018.21.1.62_ref13) 2016; 9 Koubková (10.4048/jbc.2018.21.1.62_ref18) 2014; 27 Zhang (10.4048/jbc.2018.21.1.62_ref30) 2016; 7 |
References_xml | – volume: 67 start-page: 439 year: 2017 ident: 10.4048/jbc.2018.21.1.62_ref3 publication-title: CA Cancer J Clin doi: 10.3322/caac.21412 – volume: 47 start-page: 64 year: 2015 ident: 10.4048/jbc.2018.21.1.62_ref7 publication-title: Cancer Res Treat doi: 10.4143/crt.2013.215 – volume: 12 start-page: 138 year: 2012 ident: 10.4048/jbc.2018.21.1.62_ref16 publication-title: BMC Cancer doi: 10.1186/1471-2407-12-138 – volume: 65 start-page: 87 year: 2015 ident: 10.4048/jbc.2018.21.1.62_ref1 publication-title: CA Cancer J Clin doi: 10.3322/caac.21262 – volume: 27 start-page: 11 year: 2014 ident: 10.4048/jbc.2018.21.1.62_ref18 publication-title: Klin Onkol doi: 10.14735/amko201411 – volume: 16 start-page: 566 year: 2007 ident: 10.4048/jbc.2018.21.1.62_ref6 publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.EPI-06-0782 – volume: 471 start-page: 85 year: 2009 ident: 10.4048/jbc.2018.21.1.62_ref17 publication-title: Methods Mol Biol doi: 10.1007/978-1-59745-416-2_5 – volume: 27 start-page: 1068 year: 2017 ident: 10.4048/jbc.2018.21.1.62_ref28 publication-title: Thyroid doi: 10.1089/thy.2016.0655 – volume: 12 start-page: e0185485 year: 2017 ident: 10.4048/jbc.2018.21.1.62_ref9 publication-title: PLoS One doi: 10.1371/journal.pone.0185485 – volume: 56 start-page: 1213 year: 2015 ident: 10.4048/jbc.2018.21.1.62_ref20 publication-title: Yonsei Med J doi: 10.3349/ymj.2015.56.5.1213 – volume: 15 start-page: 191 issue: Suppl 1 year: 1985 ident: 10.4048/jbc.2018.21.1.62_ref22 publication-title: Jpn J Clin Oncol – volume: 74 start-page: 702 year: 2008 ident: 10.4048/jbc.2018.21.1.62_ref10 publication-title: Am Surg doi: 10.1177/000313480807400806 – volume: 10 start-page: XD03 year: 2016 ident: 10.4048/jbc.2018.21.1.62_ref12 publication-title: J Clin Diagn Res – volume: 36 start-page: 463 year: 2016 ident: 10.4048/jbc.2018.21.1.62_ref23 publication-title: Ann Lab Med doi: 10.3343/alm.2016.36.5.463 – volume: 95 start-page: e3299 year: 2016 ident: 10.4048/jbc.2018.21.1.62_ref15 publication-title: Medicine (Baltimore) doi: 10.1097/MD.0000000000003299 – volume: 106 start-page: dju289 year: 2014 ident: 10.4048/jbc.2018.21.1.62_ref5 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/dju289 – volume: 16 start-page: 4921 year: 2015 ident: 10.4048/jbc.2018.21.1.62_ref8 publication-title: Asian Pac J Cancer Prev doi: 10.7314/APJCP.2015.16.12.4921 – volume: 33 start-page: 3891 year: 2013 ident: 10.4048/jbc.2018.21.1.62_ref25 publication-title: Anticancer Res – volume: 9 start-page: 387 year: 2016 ident: 10.4048/jbc.2018.21.1.62_ref13 publication-title: Case Rep Oncol doi: 10.1159/000447348 – volume: 25 start-page: 231 year: 2016 ident: 10.4048/jbc.2018.21.1.62_ref27 publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.EPI-15-0833 – volume: 7 start-page: 52450 year: 2016 ident: 10.4048/jbc.2018.21.1.62_ref30 publication-title: Oncotarget doi: 10.18632/oncotarget.9547 – volume: 353 start-page: 1784 year: 2005 ident: 10.4048/jbc.2018.21.1.62_ref4 publication-title: N Engl J Med doi: 10.1056/NEJMoa050518 – volume: 20 start-page: 1 year: 2017 ident: 10.4048/jbc.2018.21.1.62_ref14 publication-title: J Breast Cancer doi: 10.4048/jbc.2017.20.1.1 – volume: 39 start-page: 667 year: 2011 ident: 10.4048/jbc.2018.21.1.62_ref19 publication-title: J Int Med Res doi: 10.1177/147323001103900237 – volume: 103 start-page: 1111 year: 2012 ident: 10.4048/jbc.2018.21.1.62_ref21 publication-title: Cancer Sci doi: 10.1111/j.1349-7006.2012.02254.x – volume: 152 start-page: 444 year: 2010 ident: 10.4048/jbc.2018.21.1.62_ref29 publication-title: Ann Intern Med doi: 10.7326/0003-4819-152-7-201004060-00009 – volume: 213 start-page: 574 year: 2017 ident: 10.4048/jbc.2018.21.1.62_ref11 publication-title: Pathol Res Pract doi: 10.1016/j.prp.2017.01.003 – volume: 12 start-page: 353 year: 2011 ident: 10.4048/jbc.2018.21.1.62_ref26 publication-title: Lancet Oncol doi: 10.1016/S1470-2045(11)70061-4 – volume: 19 start-page: 1 year: 2016 ident: 10.4048/jbc.2018.21.1.62_ref2 publication-title: J Breast Cancer doi: 10.4048/jbc.2016.19.1.1 – volume: 122 start-page: 3673 year: 2016 ident: 10.4048/jbc.2018.21.1.62_ref24 publication-title: Cancer doi: 10.1002/cncr.30248 |
SSID | ssj0064377 |
Score | 2.2316551 |
Snippet | Breast cancer is one of the most common malignancies worldwide and the second most common cancer among Korean women. The prognosis of breast cancer is poor in... Purpose: Breast cancer is one of the most common malignancies worldwide and the second most common cancer among Korean women. The prognosis of breast cancer is... |
SourceID | nrf pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 62 |
SubjectTerms | Original 일반외과학 |
Title | Clinical Characteristics and Prognosis Associated with Multiple Primary Cancers in Breast Cancer Patients |
URI | https://www.ncbi.nlm.nih.gov/pubmed/29628985 https://www.proquest.com/docview/2023411332 https://pubmed.ncbi.nlm.nih.gov/PMC5880967 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002327984 |
Volume | 21 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Journal of Breast Cancer, 2018, 21(1), 85, pp.62-69 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3JTsMwELVYLlwQiK0slUFcOCTYjrP0hKACARKIA5W4WXbiQGiVQlIk-HtmkrS0qHCKlDi27PEyzzPzhpBjw2wQWo1-OiJ0MJbRMcLXDk8x6hIAgqlyA97dB9c9efvkP_2ERzcDWM6FdphPqlcM3M_3rzNY8KC_uhJpZ18NchHyyBXc5S5uyMuVtQgd-eTEpoAWqirVSghLHNTkxmg5twakCO4EgEUwxfLUebWYF-k8VfS3R-XUEXW1RlYb3ZKe15NhnSzYfINkDfPngHZnuZmpzhP6UAzR0y4r6VhONqF4N0vvGk9DKFLxUdAuzo-ipFlOL9CTfdS8oQ81NWu5SXpXl4_da6fJr-DE0mMjBwMQTBAKmXop6Hlx5HlcC246vk6Ekb6JQpmGjKXICcNEynRspNEJRxIwH86-LbKUD3O7Q2hkWaIBa2oZJNIyHVljjPVYJ018jF5tkdPxKKq4IR_HHBgDBSAERaBABApFoARXXAWiRU4mf7zVHf2n7BEIRvXjTCFbNj6fh6pfKMAENwpAkQ8QokUOx3JTsITQLqJzO_woFWaQlxzAOlS0Xctx0uR4GrRIOCPhSQFscPZLnr1UNN0-bI2dINz9s849soK9qD3a9snSqPiwB6DijEy7uhpoV_P3G3Wd9yY |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinical+Characteristics+and+Prognosis+Associated+with+Multiple+Primary+Cancers+in+Breast+Cancer+Patients&rft.jtitle=Journal+of+breast+cancer&rft.au=Kim%2C+Bong+Kyun&rft.au=Oh%2C+Se+Jeong&rft.au=Song%2C+Jeong-Yoon&rft.au=Lee%2C+Han-Byoel&rft.date=2018-03-01&rft.issn=1738-6756&rft.volume=21&rft.issue=1&rft.spage=62&rft_id=info:doi/10.4048%2Fjbc.2018.21.1.62&rft_id=info%3Apmid%2F29628985&rft.externalDocID=29628985 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1738-6756&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1738-6756&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1738-6756&client=summon |